» Articles » PMID: 39894898

Demographic Disparities and Factors Influencing Cancer Treatment Decision-Making

Overview
Journal J Cancer Educ
Publisher Springer
Date 2025 Feb 2
PMID 39894898
Authors
Affiliations
Soon will be listed here.
Abstract

This study aims to explore disparities in cancer treatment decision-making and the factors associated with the decision to pursue treatment. We used Behavioral Risk Factor Surveillance System (BRFSS) data collected between 2017 and 2022. We employed the PRECEDE-PROCEED model to guide our analysis of factors associated with treatment decisions. Descriptive statistics and multivariable logistic regression analysis were conducted to assess the association between treatment decision-making and the predisposing, enabling, and reinforcing factors (following the PRECEDE-PROCEED model). All analyses were weighted and adjusted for the demographic characteristics of the participants. Our sample included N = 19,388 cancer patients, 20.98% of whom refused treatment. American Indians, younger adults, and breast cancer patients were more likely to decide to go for treatment. Patients who had private insurance (OR = 1.25, P = .037) and those who did not have problems affording care (OR = 1.22, P = .02) were more likely to decide to get treatment. The more patients had regular doctors, the more they decided to continue to pursue treatment for cancer (Only one doctor: OR = 1.20, P = .042; More than one: OR = 1.28, P = .007). Finally, the more days patients experienced a bad health situation, the more they decided to have cancer treatment (for 14 + days with bad health: OR = 1.20, P < .001). The results suggest the need for enhanced patient education to improve cancer treatment adherence and informed decision-making. It highlights the importance of culturally tailored educational programs, age-related concerns, addressing financial barriers, and emphasizing the importance of regular healthcare visits for cancer patients.

References
1.
Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L . Current Challenges in Cancer Treatment. Clin Ther. 2016; 38(7):1551-66. DOI: 10.1016/j.clinthera.2016.03.026. View

2.
Khankeh H, Vojdani R, Saber M, Imanieh M . How do cancer patients refuse treatment? A grounded theory study. BMC Palliat Care. 2023; 22(1):10. PMC: 9903566. DOI: 10.1186/s12904-023-01132-5. View

3.
Huchcroft S, Snodgrass T . Cancer patients who refuse treatment. Cancer Causes Control. 1993; 4(3):179-85. DOI: 10.1007/BF00051311. View

4.
Choi H, Park B, Ahn S . Untreated head and neck cancer in Korea: a national cohort study. Eur Arch Otorhinolaryngol. 2016; 274(3):1643-1650. DOI: 10.1007/s00405-016-4392-8. View

5.
Chen S, Kung P, Huang K, Wang Y, Tsai W . Characteristics of the Delayed or Refusal Therapy in Breast Cancer Patients: A Longitudinal Population-Based Study in Taiwan. PLoS One. 2015; 10(6):e0131305. PMC: 4482743. DOI: 10.1371/journal.pone.0131305. View